-+ 0.00%
-+ 0.00%
-+ 0.00%

PARABILIS MEDICINES-TO USE ABOUT $130 MLN OF IPO PROCEEDS TO ADVANCE PIPELINE OF ADDITIONAL PROGRAMS

Reuters·06/04/2026 10:18:14

Please log in to view news